Page last updated: 2024-11-02

4-phenylbutyric acid and Hemophilia B

4-phenylbutyric acid has been researched along with Hemophilia B in 1 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Hemophilia B: A deficiency of blood coagulation factor IX inherited as an X-linked disorder. (Also known as Christmas Disease, after the first patient studied in detail, not the holy day.) Historical and clinical features resemble those in classic hemophilia (HEMOPHILIA A), but patients present with fewer symptoms. Severity of bleeding is usually similar in members of a single family. Many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. Treatment is similar to that for hemophilia A. (From Cecil Textbook of Medicine, 19th ed, p1008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pignani, S1
Todaro, A1
Ferrarese, M1
Marchi, S1
Lombardi, S1
Balestra, D1
Pinton, P1
Bernardi, F1
Pinotti, M1
Branchini, A1

Other Studies

1 other study available for 4-phenylbutyric acid and Hemophilia B

ArticleYear
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation.
    Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:10

    Topics: Blood Coagulation; Dose-Response Relationship, Drug; Factor IX; HEK293 Cells; Hemophilia B; Humans;

2018